Thyroid Eye Disease
📧 Sign up to get email alerts when something new happens for Thyroid Eye Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease [Phase 2]
Phase 2 clinical trial update for TOUR006 evaluating efficacy and safety in adults with Thyroid Eye Disease; the study is currently ACTIVE_N…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease [Phase 2]
Phase 2 clinical trial update on tofacitinib for glucocorticoid-resistant moderate-to-severe Thyroid Eye Disease; the study is currently act…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease [Phase 1]
This is a Phase 1 clinical trial investigating Lu AG22515 in adults with moderate-to-severe Thyroid Eye Disease; the study status is active …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED) [Phase 3]
Clinical trial update for VRDN-003 in active Thyroid Eye Disease; the Phase 3 study is ongoing but not currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED) [Phase 3]
This update notes a Phase 3 safety and tolerability trial of VRDN-003 in Thyroid Eye Disease. The study is currently active and not recruiti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease [Phase 2]
Open-label rollover Phase 2 trial evaluating the efficacy and safety of AMG 732 in participants with Thyroid Eye Disease; the study status i…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: MHB018A Treatment in Patients With Chronic Thyroid Eye Disease [Phase 3]
This clinical trial update indicates that the Phase 3 study of MHB018A for chronic thyroid eye disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease [Phase 3]
An ongoing Phase 3 open-label extension trial evaluating MHB018A in people with Thyroid Eye Disease, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting
Clinical trial from Imperial College London evaluating the pharmacokinetics of high-dose prednisolone in acute and chronic inflammatory sett…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Evaluating the Efficacy and Safety of Teprotumumab N01 in Patients With Thyroid Eye Disease. [NA]
A clinical trial update indicating that Teprotumumab N01 is being studied to evaluate its efficacy and safety in patients with Thyroid Eye D…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease [Phase 3]
A Phase 3 trial is evaluating satralizumab for Thyroid Eye Disease, with the study currently listed as ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study of GenSci098 in Subjects With Active Thyroid Eye Disease [Phase 1]
A Phase 1 study evaluating GenSci098 in adults with active thyroid eye disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease [Phase 3]
This clinical trial update describes a Phase 3 study comparing subcutaneous teprotumumab with placebo in adults with moderate-to-severe acti…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Comparison of the Efficacy and Safety of 4 vs. 8 Treatments With Tepezza (Teprotumumab) for Thyroid Eye Disease [Phase 4]
Phase 4 clinical trial comparing 4 versus 8 Tepezza treatment regimens for Thyroid Eye Disease. The trial is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of ZL-1109 in Chinese participants with active Thyroid Eye Disease is currently …
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease [Phase 4]
Clinical trial update for Teprotumumab N01 in active thyroid eye disease is listed as Phase 4 and not yet recruiting.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of IBI311 in Subjects With Inactive Thyroid Eye Disease [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of IBI311 in inactive thyroid eye disease and is currently recruiting. Sponso…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED) [Phase 3]
Phase 3 study evaluating VRDN-003 in chronic Thyroid Eye Disease is active but not currently recruiting; no efficacy or safety results are r…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy Participants [Phase 1]
Phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of NTB003 in healthy participants. Thyroid eye disease is listed as…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of IBI311 for inactive Thyroid-associated ophthalmopathy (thyroid eye disease) is …
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Multi-modal Medical Images for Extraocular Muscle Fibrosis Assessment
This is an update on a completed clinical trial evaluating multi-modal medical imaging to assess extraocular muscle fibrosis in thyroid eye …
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) [Phase 2, Phase 3]
This document notes an ongoing Phase 2b/Phase 3 trial evaluating linsitinib for Thyroid Eye Disease, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: A Study of SCTT11 in Healthy Participants and Participants with Thyroid Eye Disease. [Phase 1, Phase 2]
A clinical trial update for SCTT11 in healthy participants and Thyroid Eye Disease patients, currently not yet recruiting (Phase 1 and Phase…
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease
Amgen's expanded access protocol for Teprotumumab (HZN-001) to treat active thyroid eye disease (Graves' orbitopathy) has been updated; the …
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Study on Efficacy of Add on Selenium in Mild-to-moderate Graves Ophthalmopathy [NA]
This clinical trial is evaluating selenium as an add-on therapy for mild-to-moderate Graves' ophthalmopathy (thyroid eye disease); the study…